Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 17(7)2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38955381

ABSTRACT

Percutaneous testicular varicocele embolisation for symptomatic and subfertile males is often preferred over surgical ligation of the gonadal vein due to its minimally invasive approach and reduced complication rate. Glues, coils, vascular plugs, balloons and sclerosants are used in various combinations to achieve sufficient venous occlusion. Here, we report on the first known case of sclerosant material migration beyond the placement of an embolisation coil for treatment of a varicocele, resulting in a left renal vein thrombus. A man in his 20s presented to the emergency department 2 days following uncomplicated left varicocele embolisation with acute left-sided abdominal pain, found to have sclerosant material causing an ipsilateral non-occlusive left renal vein thrombus with extension towards his inferior vena cava on CT. He was treated with 3 months of anticoagulation and follow-up imaging at 3 months showed resolution of this thrombus without renal impairment.


Subject(s)
Embolization, Therapeutic , Renal Veins , Varicocele , Humans , Male , Varicocele/therapy , Embolization, Therapeutic/methods , Embolization, Therapeutic/adverse effects , Renal Veins/diagnostic imaging , Foreign-Body Migration , Sclerosing Solutions/administration & dosage , Sclerosing Solutions/therapeutic use , Adult , Young Adult , Tomography, X-Ray Computed
2.
BMJ Case Rep ; 17(4)2024 Apr 29.
Article in English | MEDLINE | ID: mdl-38684348

ABSTRACT

Bladder paragangliomas (bPGLs) account for only 0.06% of all bladder tumours, most commonly presenting with post-micturition syncope and hypertensive crisis. Silent paragangliomas are very rare, and failure to recognise them in the perioperative setting can precipitate a hypertensive crisis in the absence of sufficient alpha-blockade. Here, we describe a case of unrecognised bPGL in a woman with pre-existing hypertension and a single prior episode of haematuria thought to be related to urothelial carcinoma. She was found to have a low-grade non-invasive papillary urothelial carcinoma (potentially the cause of her haematuria) and an unrelated vascular-appearing tumour causing hypertensive crisis and broad complex tachycardia on resection. This was confirmed to be a bPGL on histology for which she underwent definitive management with a partial cystectomy following blood pressure management.


Subject(s)
Cystectomy , Hypertension , Paraganglioma , Urinary Bladder Neoplasms , Humans , Female , Urinary Bladder Neoplasms/complications , Paraganglioma/complications , Paraganglioma/surgery , Hypertension/etiology , Hypertension/complications , Hematuria/etiology , Middle Aged , Hypertensive Crisis
4.
Sci Rep ; 10(1): 14202, 2020 08 26.
Article in English | MEDLINE | ID: mdl-32848161

ABSTRACT

Bacterial nanocellulose (BNC) is a nanofibrillar polymer that possesses unique characteristics such as high chemical purity, mechanical strength, flexibility, and absorbency. In addition, different bacterial strains can form nanocellulose (NC) in multiple shapes and sizes. This study describes the first report of a marine Bacillus strain that is able to synthesize NC. The strain identified as B. velezensis SMR based on 16S rDNA sequencing, produced highly structured NC, as confirmed by X-ray diffraction (XRD) and Scanning Electron Microscopic Analysis (SEM). In Hestrin-Schramm (HS) medium, B. velezensis SMR produced twice the quantity of BNC in comparison to the reference strain, G. xylinus ATCC 10245. The ability of B. velezensis SMR to produce NC using different industrial waste materials as growth media was tested. Growth in Ulva seaweed extract supported a 2.5-fold increase of NC production by B. velezensis SMR and a threefold increase in NC production by G. xylinus ATCC 10245. As proof of principle for the usability of NC from B. velezensis SMR, we successfully fabricated a BNC-based polyvinyl alcohol hydrogel (BNC-PVA) system, a promising material used in different fields of application such as medicine, food, and agriculture.


Subject(s)
Bacillus/metabolism , Cellulose/biosynthesis , Biomass , Cellulose/chemistry , Cellulose/ultrastructure , Hydrogels , Nanofibers/chemistry , Nanofibers/ultrastructure , Polyvinyl Alcohol , Spectroscopy, Fourier Transform Infrared , Thermogravimetry , Ulva , X-Ray Diffraction
5.
Pain ; 158(11): 2196-2202, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28825602

ABSTRACT

Psoriasis is often accompanied by itch, but the mechanisms behind this symptom remain elusive. Dynamic changes in epidermal innervation have been observed under chronic itch conditions. Therefore, we investigated whether epidermal innervation is altered in the imiquimod-induced psoriasis mouse model, whether blockade of neurotrophic growth factor signaling can reduce these changes, and whether this system can impact psoriatic itch. Over the 7-day time course of imiquimod treatment, the density of epidermal nonpeptidergic nerves significantly increased, whereas the density of peptidergic nerves significantly decreased. The nonpeptidergic epidermal nerves expressed glial cell line-derived neurotrophic factor (GDNF) family receptor GFRα-1 and GFRα-2, the ligand-binding domains for GDNF and neurturin (NRTN). The NRTN mRNA expression was elevated in the skin of imiquimod-treated mice, whereas the GDNF mRNA expression was decreased. Treatment of imiquimod-challenged mice with an NRTN-neutralizing antibody significantly reduced nonpeptidergic nerve density as well as spontaneous scratching. These results indicate that NRTN contributes to an increase in the epidermal density of nonpeptidergic nerves in the imiquimod-induced psoriasis model, and this increase may be a factor in chronic itch for these mice. Therefore, inhibition of NRTN could be a potential treatment for chronic itch in psoriasis.


Subject(s)
Nerve Fibers/pathology , Neurturin/metabolism , Pruritus/etiology , Psoriasis/complications , Psoriasis/pathology , Skin/innervation , Adjuvants, Immunologic/therapeutic use , Aminoquinolines/therapeutic use , Animals , Antibodies/therapeutic use , Calcitonin Gene-Related Peptide/metabolism , Disease Models, Animal , Gene Expression Regulation/physiology , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics , Glial Cell Line-Derived Neurotrophic Factor Receptors/metabolism , Imiquimod , Male , Mice , Mice, Inbred C57BL , Neurturin/genetics , Neurturin/immunology , Psoriasis/drug therapy , RNA, Messenger/metabolism , Receptors, Purinergic P2X3/metabolism
6.
Int J Mol Sci ; 18(7)2017 Jun 27.
Article in English | MEDLINE | ID: mdl-28654000

ABSTRACT

Non-melanomatous skin cancers (NMSCs), which include basal and squamous cell carcinoma (BCC and SCC respectively), represent a significant burden on the population, as well as an economic load to the health care system; yet treatments of these preventable cancers remain ineffective. Studies estimate that there has been a 2-fold increase in the incidence of NMSCs between the 1960s and 1980s. The increase in cases of NMSCs, as well as the lack of effective treatments, makes the need for novel therapeutic approaches all the more necessary. To rationally develop more targeted treatments for NMSCs, a better understanding of the cell of origin, in addition to the underlying pathophysiological mechanisms that govern the development of these cancers, is urgently required. Research over the past few years has provided data supporting both a "bottom up" and "top down" mechanism of tumourigenesis. The "bottom up" concept involves a cancer stem cell originating in the basal compartment of the skin, which ordinarily houses the progenitor cells that contribute towards wound healing and normal cell turnover of overlying epidermal skin layers. The "top down" concept involves a more differentiated cell undergoing genetic modifications leading to dedifferentiation, giving rise to cancer initiating cells (CICs). This review explores both concepts, to paint a picture of the skin SCC cell of origin, the underlying biology, and also how this knowledge might be exploited to develop novel therapies.


Subject(s)
Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Epidermis/pathology , Neoplastic Stem Cells/pathology , Skin Neoplasms/pathology , Skin/pathology , Animals , Carcinogenesis/genetics , Carcinogenesis/pathology , Carcinoma, Basal Cell/genetics , Carcinoma, Squamous Cell/genetics , Cell Dedifferentiation , DNA-Binding Proteins/analysis , DNA-Binding Proteins/genetics , Epidermis/metabolism , Gene Expression Regulation, Neoplastic , Humans , Neoplastic Stem Cells/metabolism , Skin/metabolism , Skin Neoplasms/genetics , Transcription Factors/analysis , Transcription Factors/genetics
7.
Pain ; 157(11): 2536-2543, 2016 11.
Article in English | MEDLINE | ID: mdl-27437787

ABSTRACT

Itch is a major indicator of psoriasis, but the underlying mechanisms behind this symptom are largely unknown. To investigate the neuronal mechanisms of psoriatic itch, we tested whether mice subjected to the imiquimod-induced psoriasis model exhibit itch-associated behaviors. Mice received daily topical applications of imiquimod to the rostral back skin for 7 days. Imiquimod-treated mice exhibited a significant increase in spontaneous scratching behavior directed to the treated area as well as touch-evoked scratching (alloknesis). To characterize this model, we measured the mRNA expression levels of pruritogens and itch-relevant receptors/channels using real-time reverse transcription PCR. The mRNA expression of MrgprA3, MrgprC11, and MrgprD decreased gradually over time in the dorsal root ganglion (DRG) cells. There was no significant change in the mRNA expression of TRPV1 or TRPA1 in DRG cells. TRPV4 mRNA expression was transiently increased in the DRG cells, whereas TRPM8 mRNA was significantly decreased. The mRNA expression levels of histidine decarboxylase and tryptophan hydroxylase 1, as well as the intensity of histamine and serotonin immunoreactivity, were transiently increased in the skin on day 2, returning to baseline by day 7. Histamine H1-receptor antagonists, chlorpheniramine and olopatadine, significantly inhibited spontaneous scratching on day 2, but not day 7. Neither chlorpheniramine nor olopatadine affected alloknesis on day 2 or day 7. These results may reflect the limited antipruritic effects of histamine H1-receptor antagonists on human psoriasis. The imiquimod-induced psoriasis model seems to be useful for the investigation of itch and its sensitization in psoriasis.


Subject(s)
Adjuvants, Immunologic/toxicity , Aminoquinolines/toxicity , Disease Models, Animal , Pruritus/chemically induced , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antipruritics/therapeutic use , Chlorpheniramine/therapeutic use , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Gene Expression Regulation/drug effects , Histidine Decarboxylase/genetics , Histidine Decarboxylase/metabolism , Imiquimod , Male , Mice , Mice, Inbred C57BL , Olopatadine Hydrochloride/therapeutic use , Pain Measurement , Pruritus/drug therapy , Pruritus/pathology , Random Allocation , Skin/metabolism , Skin/pathology , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism , Tryptophan Hydroxylase/genetics , Tryptophan Hydroxylase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...